Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia

Archives of General Psychiatry

Volumn 59, Issue 6, 2002, Pages 521-529

  Heckers, Stephan ^a,b   Stone, David ^a   Walsh, John ^a   Shick, John ^a   Koul, Pamposh ^a   Benes, Francine M ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; ISOENZYME; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; IN SITU HYBRIDIZATION; MALE; MANIC DEPRESSIVE PSYCHOSIS; SCHIZOPHRENIA; TISSUE DISTRIBUTION;

EID: 0036269901     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.6.521     Document Type: Article

References (38)

1. Salient features of synaptic organisation in the cerebral cortex
2. Interneurons of the hippocampus
3. Anatomical organization of the parahippocampal-hippocampal network
4. Prominence of direct entorhinal-CA1 pathway activation in sensorimotor and cognitive tasks revealed by 2-DG functional mapping in nonhuman primate
5. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder
6. Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain
7. Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain
8. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
9. Morphometric analyses of the hippocampal formation in schizophrenic brain
10. Hippocampal neuron number in schizophrenia: A stereological study
11. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions
12. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
13. Reelin and GAD67 downregulation and psychosis vulnerability
14. Two isoforms of glutamate decarboxylase: Why?
15. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys
16. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
17. 67 messenger RNA expression in a subset of prefrontal cortical -ami-nobutyric acid neurons in subjects with schizophrenia
18. 67) expression in schizophrenia and bipolar disorder
19. Diagnostic criteria for use in psychiatric research
20. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene
21. New concepts in mood stabilization: Evidence for the effectiveness of valproate and lamotrigine
22. Localization of cells preferentially expressing GAD67 with negligible GAD65 transcripts in the rat hippocampus: A double in situ hybridization study
23. Distribution of GABAergic cells and fibers in the hippocampal formation of the macaque monkey: An immunohistochemical and in situ hybridization study
24. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum
25. Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons
26. Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles
27. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex
28. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain
29. Patterns of cerebral blood flow in schizophrenia
30. The left medial temporal region and schizophrenia: A PET study
31. Regional cerebral blood flow in patients with schizophrenia: A preliminary report
32. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features
33. Regional cerebral blood flow in patients with schizophrenia: Relevance to symptom structures
34. A functional neuroanatomy of hallucinations in schizophrenia
35. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
36. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia
37. Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain